A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib

Clinical trial NCT07689201 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07689201
Sponsor: GlaxoSmithKline
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Neoplasms

Start date: 2026-08-31
Primary completion: 2027-12-13
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.